Skip to main content

Published locations for HSCT or systemic treatment should be offered to HIV+ patients with lymphoma

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. HSCT or systemic treatment should be offered to HIV+ patients with lymphoma

User login

  • Reset your password
  • /content/hsct-or-systemic-treatment-should-be-offered-hiv-patients-lymphoma
  • /hematologynews/article/225543/b-cell-lymphoma/hsct-or-systemic-treatment-should-be-offered-hiv
  • /idpractitioner/article/225543/b-cell-lymphoma/hsct-or-systemic-treatment-should-be-offered-hiv
  • /internalmedicinenews/article/225543/b-cell-lymphoma/hsct-or-systemic-treatment-should-be-offered-hiv
  • /hematology-oncology/article/225543/b-cell-lymphoma/hsct-or-systemic-treatment-should-be-offered-hiv
  • /infectiousdisease/article/225543/b-cell-lymphoma/hsct-or-systemic-treatment-should-be-offered-hiv
  • /internalmedicine/article/225543/b-cell-lymphoma/hsct-or-systemic-treatment-should-be-offered-hiv
  • /b-cell-lymphoma-icymi/article/225543/b-cell-lymphoma/hsct-or-systemic-treatment-should-be-offered